Pagina inicial 1
Continue Watching
Últimos vídeos
Últimos vídeos
Brightcove Home Latest Listing
Câncer de mama
Câncer de mama
Brightcove Cards Listing
Câncer de próstata
Câncer de próstata
Brightcove Cards Listing
Mieloma múltiplo
Mieloma múltiplo
Brightcove Cards Listing
Popular em MedEnrich
Popular em MedEnrich
Popular in Sem nome
Mieloma múltiplo2m 36s
Tips on Effective Management of Bone Disease in Multiple Myeloma
Bisphosphonates, mainly zolendronic acid is the preferred drug of choice in treating patients with bone disease in multiple myeloma.
1
Tips on Effective Management of Bone Disease in...
Myelodysplastic Syndromes31m 24s
Improving Diagnosis of MDS -Innovative Solutions
Modern Web -Based digital tools based on 10 routinely used clinical parameters and Gradient Based Model can help in non-invasive diagnosis of MDS.
1
Improving Diagnosis of MDS -Innovative Solutions
Mieloma múltiplo3m 12s
Tips for Optimising Long Term Lenalidomide Maintenance in Multiple Myeloma
Dr. Joseph Mikhael explains the triad of maintaining the patients on term Lenalidomide maintenance.
1
Tips for Optimising Long Term Lenalidomide...
Mieloma múltiplo8m 23s
Treatment of High Risk Myeloma Patients
While treating high risk patients it is critical to address complex biology & maximize the response for individual patients by gaining depth of response & maintaining that response for long duration. To ensure good quality of life patients should hav
1
Treatment of High Risk Myeloma Patients
Câncer de próstata6m 1s
Androgen Receptor Targeted Therapies in patients with Cardiovascular Co Morbidities
Referring the patients to cardiologist is an important aspect of managing patients with cardiovascular co-morbidities.
1
Androgen Receptor Targeted Therapies in patients...
3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
1
Duration of trastuzumab in patients with Her2...
3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
1
Duration of trastuzumab in patients with Her2...
Mieloma múltiplo4m 12s
Key Practice Points -Myeloma Related Renal Impairment
In patients with renal impairment primary goal is improvement of Renal Function which is associated with improved treatment outcomes. 50% of patients present renal impairment and renal impairment is severe in 15% of patients.
1
Key Practice Points -Myeloma Related Renal...
Myelodysplastic Syndromes7m 3s
Clinical Application of Web Based Tool for Improving MDS Diagnosis
Gradient Based Model based on 10 routinely used parameters (Age, Gender, Hb, WBC, MCV, Platelets, Neutrophils, Monocytes, Glucose, Creatinine) is now available to facilitate non-invasive diagnosis of MDS.
1
Clinical Application of Web Based Tool for...
Mieloma múltiplo7m 22s
Using Bone Targeted Therapy in Special Situations in Multiple Myeloma
Bone targeting agents have different toxicities and rare complications which are dependent on the exposure to the specific treatment. Watch detailed video on MedEnrich on use of bone targeted agent in Multiple Myeloma
1
